Investor

Relations

SEC Filings

Document Date	Form	Description	Filing Group	View
May 31, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	Other	View HTML 0001273087-23-000116.pdf 0001273087-23-000116.rtf 0001273087-23-000116.xls
May 23, 2023	SC 13D/A	An amendment to a SC 13D filing	Other	View HTML 0001193125-23-151890.pdf 0001193125-23-151890.rtf 0001193125-23-151890.xls
May 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001209191-23-029521.pdf 0001209191-23-029521.rtf 0001209191-23-029521.xls
May 09, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0000950170-23-019172.pdf 0000950170-23-019172.rtf 0000950170-23-019172.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
Mar 31, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0000950170-23-019176.pdf 0000950170-23-019176.rtf 0000950170-23-019176.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
May 01, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001209191-23-026798.pdf 0001209191-23-026798.rtf 0001209191-23-026798.xls
Jun 13, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	View HTML 0000950170-23-015020.pdf 0000950170-23-015020.rtf 0000950170-23-015020.xls
Apr 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0000950170-23-015026.pdf 0000950170-23-015026.rtf 0000950170-23-015026.xls
Dec 31, 2022	ARS	An annual report to security holders	Annual Filings	View HTML 0000950170-23-015028.pdf 0000950170-23-015028.rtf
Apr 03, 2023	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001209191-23-022464.pdf 0001209191-23-022464.rtf 0001209191-23-022464.xls

Data provided by Kaleidoscope.

Inozyme is a global leader in developing therapies for rare diseases.

321 Summer Street, Suite 400 Boston, MA 02210